All relevant data are within the manuscript and its Supporting Information files. Raw sequence reads were deposited in NCBI Sequence Read Archive (SRA) under BioProject ID PRJNA590365 (<https://www.ncbi.nlm.nih.gov/sra/PRJNA590365>).

Introduction {#sec001}
============

Chronic constipation (CC), also frequently referred to as functional constipation, colonic inertia, slow transit constipation, is a prevalent, distressing gastrointestinal disorder. Its etiology and pathophysiology remain poorly understood and is most likely multifactorial \[[@pone.0235985.ref001]--[@pone.0235985.ref003]\]. CC may develop as the result of sedentary lifestyle, the intake of harmful food, bad ecology, anomaly of colonic structure and its location in the abdominal cavity. Thus, constipation syndrome may be associated with dolichocolon, idiopathic megacolon, Payr's syndrome, ptosis of the transverse colon, sigmocele, or may occur without anatomical abnormalities \[[@pone.0235985.ref004], [@pone.0235985.ref005]\]. The incidence rates of CC are higher in women than in men and they usually increase with age \[[@pone.0235985.ref006]\]. Since CС significantly reduces the patients' life quality and can hardly be treated, the improvement of diagnostics and treatment of СС is one of the most important medical and social problems \[[@pone.0235985.ref007], [@pone.0235985.ref008]\]. Although conservative treatment of CC remains prevalent, surgical colonic resection has become more frequent nowadays, particularly in severe cases involving gut anatomical abnormality and dilatation, and has demonstrated long-term positive results \[[@pone.0235985.ref009]--[@pone.0235985.ref012]\].

Acquired and inherited anatomical and morphological changes in the colon are most frequently characterized by slow colonic transit and include a dilated or redundant colon like Hirschsprung's disease, idiopathic megacolon, or dolichocolon \[[@pone.0235985.ref010], [@pone.0235985.ref013]--[@pone.0235985.ref015]\]. The etiology of idiopathic megacolon is not clear, and several alterations have been found in the morphology, functions, and regulation of intestinal motility \[[@pone.0235985.ref016]\]. Concerning smooth muscle function, decreases in frequency, amplitude, and duration of propulsive contractions of the colon have been reported in CC patients \[[@pone.0235985.ref017]\]. The evidence on the role of cholinergic innervation in the pathogenesis of CC is controversial. Some data have indicated a reduced activity of cholinergic nerves in patients with CC \[[@pone.0235985.ref018]\], thus suggesting a beneficial effect of cholinergic stimulation of distal colon \[[@pone.0235985.ref019], [@pone.0235985.ref020]\]. Another study has shown hypersensitivity of the colonic circular smooth muscle to cholinergic stimulation in CC patients \[[@pone.0235985.ref020]\]. Moreover, the administration of cholinesterase inhibitor did not improve the colonic motility in constipated patients \[[@pone.0235985.ref021]\]. It is still unclear whether constipation in a dilated or redundant colon is associated with impaired molecular mechanisms of contractility or neuronal regulation of smooth muscle cells.

The gut microbiota has been suggested to play a role in the pathogenesis of CC. End-products of fermentation and other bacterial metabolites may affect intestinal motor function through the mediators released by the gut immune response, or intestinal neuroendocrine factors \[[@pone.0235985.ref022]\]. Multiples studies have revealed differences in the composition of the intestinal microbiota in constipated patients compared with healthy controls, but these results are largely contradictory. For instance, in constipated obese children significant reduction in the representation of *Prevotella* and increased abundance of several genera of *Firmicutes*, including butyrate-producing *Coprococcus*, *Roseburia* and *Faecalibacterium*, were demonstrated based on 16S rRNA gene pyrosequencing \[[@pone.0235985.ref023]\]. Using culture-based techniques it was also shown that *Coprococcus*, *Roseburia* and *Faecalibacterium* tended to be increased in constipated patients \[[@pone.0235985.ref024], [@pone.0235985.ref025]\]. On the other hand, recent metagenomic study showed a reduced level of *Coprococcus 3*, *Roseburia* and *Bacteroides* and an increased level of *Faecalibacterium* in stool samples from individuals with functional constipation. No difference between constipated and control samples was indicated in regard *Prevotella* \[[@pone.0235985.ref026]\]. The inconsistency which exists in literature may possibly be explained by differences in resolution potential of culture-based and molecular approaches in assessment of the bulk of gut microbiota. The unculturable part of intestinal microbiota most likely was missed in culture-based investigations of stool samples collected from constipated individuals. Besides, studying of fecal microbiota instead of mucosal one results in a limited view of the gut microbiota. Although several microbial taxa were considered as promoting the symptoms of constipation \[[@pone.0235985.ref003], [@pone.0235985.ref023], [@pone.0235985.ref026]\], the causative agent of CC has not been established yet. It's still questionable whether alterations in gut microbiota are a cause or a consequence of constipation. Indeed, dietary habits and slow colonic transit time may result in the altered gut microbiota in patients with constipation \[[@pone.0235985.ref027], [@pone.0235985.ref028]\].

The aim of the present study was to analyze the contractility and microbiota of colonic tissue samples from patients with refractory forms of CC.

Material and methods {#sec002}
====================

Clinical characteristics of patients with CC {#sec003}
--------------------------------------------

The study was approved by the Local Ethics Committees (Protocol No. 8, Kazan Federal University, 05.05.2015; Protocol No. 9, Kazan State Medical University, 24.11.2015). Written informed consent was obtained from all the patients enrolled in this study. The enrollment of participants and all the experiments complied with the relevant guidelines and institutional regulations. Data were collected from 20 patients (five males and fifteen females) who underwent colorectal surgery for refractory CC at the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, between April 2015 and March 2018 ([S1 Table](#pone.0235985.s002){ref-type="supplementary-material"}). Their age ranged from 20 to 70 years, with an average age of 42 years (σ = ±13). Constipation syndrome in test group was identified in patients with dolichocolon (12 cases) ([S1A Fig](#pone.0235985.s001){ref-type="supplementary-material"}) and idiopathic megacolon (8 cases) ([S1B Fig](#pone.0235985.s001){ref-type="supplementary-material"}). Preoperative investigations included anamnesis, clinical examination, colonoscopy, colonic transit study by the rate of passage the radiopaque markers through the gastrointestinal tract, and computed tomography colonography for obtaining three-dimensional images of colons with abnormal architectonics and unusual location in the abdominal cavity. In patients with refractory CC in order to reduce the length of the colon the following types of surgery were performed: total, subtotal colectomy, left-sided hemicolectomy, and resection of the sigmoid colon. The descending colon segments were included in all resected specimens and were used to study intestinal motility and gut microbiota.

Human tissue specimens and recording of contractile activity {#sec004}
------------------------------------------------------------

The descending colon segments were transported to the laboratory in cold saline buffer. The contractile activity was analyzed according to previous studies \[[@pone.0235985.ref029], [@pone.0235985.ref030]\]. Longitudinal and circular strips (10 × 2 mm) were cut out from the tissue retaining all the layers of the intestinal wall. Colon specimens were suspended in a tissue chamber containing 10 mL Krebs solution (mM: NaCl, 121.0; KCl, 5.9; CaCl~2~, 2.5; MgCl~2~, 1.2; NaHCO~3~, 25.0; NaH~2~PO~4~, 1.2; glucose 8.0; bubbled with a mixture of 5% CO~2~/95% O~2~, pH 7.4) constantly bubbled with 5%CO~2~/95%O~2~ and the temperature was maintained at 37°C. One end of the specimen was fixed to a hook, and the other end was attached to an isometric force transducer (TSD125C0) connected to an amplifier to record the mechanical activity (Biopac Systems, USA). Data were digitalized (25 Hz) with AcqKnowledge 4.1 software (Biopac Systems, USA). The muscle strips were equilibrated for 60--90 min with a 1.5--2 g preload and 15-min bath washouts. After this, most of the strips displayed spontaneous phasic activity. A highly concentrated KCl solution (70 mM) was used to depolarize and stimulate the tissue, in which the concentration of NaCl was equivalently reduced to maintain the osmolarity. Carbachol, an agonist of acetylcholine receptors, was cumulatively added to the bath at increasing concentrations of 0.01, 0.1, 1, 10, 100, and 200 μM. The amplitudes of spontaneous and evoked contractile responses to KCl or carbachol were analyzed in both experimental groups.

The statistical analysis was performed using OriginPro (OriginLab Corp., USA) software. To normalize the data, the amplitude of the evoked response was divided by the weight of the tissue specimen. To analyze the dose-dependence curves, we used curve-fitting by the logistic function (y = A~2~ + (A~1~-A~2~) / (1 + (x / x~0~)^p^); A~1~ --initial value, A~2~ --final value, x0 --center (x~0~ = EC~50~) and "p" is the calculated power of sigmoidal curve) \[[@pone.0235985.ref031]\]. The difference between the data were estimated using Mann-Whitney test. The null hypothesis (H~0~) was set that there is no difference in contractile activity between the constipation group and the control group. The alternative hypothesis (H~A~) was that contractility is different in these two groups. A hypothesis test was declared statistical significance for a significance level of alpha = 0.05. Data are expressed as mean ± standard error of mean (M ± SEM), and "n" indicates the number of samples.

Microbial culture methods for intestinal microbiota assessment {#sec005}
--------------------------------------------------------------

Fresh colonic samples were obtained from patients with CC (1 sample per patient; minimum 1 g) and were divided into two. One part was subjected to metagenomic sequencing to profile the entire community. The other part (0.5 g) was thoroughly washed with 10 mL of sterile physiological solution (0.85 g NaCl in 100 mL of milliQ water) for 30 min at 37°С and 180--200 rpm. The resulting suspension was serially diluted and plated onto different nutrient agar in Petri dishes as follows. A nonselective nutrient agar for the cultivation of microorganisms "BTN" (Biotechnovacia, Russia) was used as a plate count agar to assess total microbial growth. To distinguish between aerobic and facultative anaerobic bacteria, we applied pour or spread plate techniques and cultivation under aerobic or anaerobic conditions. Also, we used cabbage agar with 4% (w/v) CaCO~3~ to isolate lactic acid bacteria (LAB). *Lactobacillus* spp. were identified by using De Man, Rogosa, Sharpe (MRS) agar \[[@pone.0235985.ref032]\]. *Bifidobacterium* spp. were cultivated on Bifidobacterium agar (HiMedia Laboratories Limited, India). Bacteria of the family *Enterobacteriaceae* were inoculated onto Endo agar and SS agar ("Microgen", Russia). Plates were incubated at 37 ^o^C for 72 h. To provide anaerobic conditions, we used "Anaerogas" gas-pak sachets (NIKI MLT, Russia). Bacterial colonies were identified based on their morphological properties.

Metagenomic analyses {#sec006}
--------------------

### DNA extraction {#sec007}

Gut tissue samples were stored at --80°C before homogenization in a SuperFastPrep-1 (MP Biomedicals, USA) at 5 m/s for 2 min and DNA extraction with the Fast DNA SPIN Kit (MP Biomedicals, USA).

### 16S rRNA gene amplification and sequencing {#sec008}

Sequences of the 16S rRNA gene were analyzed by next-generation sequencing using the MiSeq system (Illumina, USA). A 16S rRNA sequencing library was constructed according to the 16S Metagenomics Sequencing Library Preparation Protocol \[[@pone.0235985.ref033]\].

A first PCR round was performed with 4 μL of DNA extracted from microdissected tissues using primers targeting the 16S rRNA gene V3 and V4 regions, forward primer 341F (`5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3′`), and reverse primer 805R (`5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3′`), where Illumina adapters are indicated in italics \[[@pone.0235985.ref034]\]. Each 30 μL PCR reaction mix contained 2.0 μL (60--100 ng) template DNA, 1.5 μL of each primer (10 μM), 0.3 μL Q5 High Fidelity DNA polymerase (NEB, USA), 6 μL 5X Q5 Reaction Buffer, 0.6 μL dNTPs (10 mM), 18.1 μL dH~2~O. The PCR conditions for DNA amplification were as follows: initial denaturation at 98 ^o^C for 30 s, followed by 30 cycles of 98 ˚C denaturation for 10s, annealing at 55 ^o^C for 20 s and extension at 72 ^o^C for 30 s. After purification of PCR products with AMPure XT magnetic beads (Invitrogen), the second PCR was performed using primers from a Nextera XT Index Kit (Illumina). Each 50 μL PCR reaction mix contained 5.0 μL purified PCR-product, 5 μL of each primer (5 μM), 0.5 μL Q5 High Fidelity DNA polymerase (NEB, USA), 10 μL 5X Q5 Reaction Buffer, 1 μL dNTPs (10 mM), and 23.5 μL dH~2~O. The PCR conditions for DNA amplification were as follows: initial denaturation at 98 ^o^C for 30 s, followed by 8 cycles of 98 ^o^C denaturation for 15 s, annealing at 55 ^o^C for 30 s, and then extension at 72 ^o^C for 30 s. PCR-products purified with AMPure XT magnetic beads (Invitrogen) were visualized using gel electrophoresis and quantified with a Qubit dsDNA HS Assay Kit (Thermo Scientific) on a Qubit 2.0 fluorometer. The sample pool (4 nM) was denatured with 0.2 N NaOH, diluted further to 4 pM, and combined with 20% (v/v) denatured 4 pM PhiX, prepared following Illumina guidelines. Sequencing was performed with an Illumina MiSeq sequencer (Illumina, San Diego, CA, USA) using Illumina V3 chemistry and paired-end 2 × 300 base pair reads. All sequencing was performed in a single MiSeq run. Initial sequence data processing was performed by the Illumina MiSeq Reporter to demultiplex samples and remove the adapter. Primer sequence data were exported in FASTQ format. Sequencing was performed at the Interdisciplinary Center of Shared Facilities, Kazan Federal University \[[@pone.0235985.ref035]\].

### Quantitative analysis of microbiome composition {#sec009}

Reads were processed and analyzed by phylogenetic and operational taxonomic unit (OTU) methods on QIIME software version 1.9.1 (<http://qiime.org/>) \[[@pone.0235985.ref036]\]. Paired-end reads were joined and then processed to remove low quality and chimeric sequence data. The rarefaction step was performed to reduce sequencing depth heterogeneity between samples. After this processing, sequences were clustered into OTUs at a sequence identity level of 97%. The latest GreenGenes database version 13.8 \[[@pone.0235985.ref037]\] was used.

To evaluate the alpha diversities of each microbiota community, we calculated phylogenetic distance metric \[PD_whole_tree\], Chao1, Shannon, and Simpson indices. Similarities between microbial compositions of samples were evaluated using the beta diversity characteristics, and both weighted and unweighted Unifrac were calculated on QIIME software. Principal coordinate analysis (PCoA) was performed to obtain the principal coordinates and visualize the species by using complex multidimensional data.

Results {#sec010}
=======

Contractility of colon muscle strips from patients with CC {#sec011}
----------------------------------------------------------

In this study we compared colon muscle contractility of eight patients with refractory forms of CC (gender distribution: 2/6 (m/f), average age: 40 years (σ = ±12), range: 20--55 years) with that of a control group consisted of five patients with small (adeno)carcinoma of the sigmoid or rectosigmoid colon (T~2-3~N~0~M~0~) not associated with intestinal motility dysfunction (gender distribution: 2/3 (m/f), average age: 67 years (σ = ±5), range: 61--73 years) ([S1 Table](#pone.0235985.s002){ref-type="supplementary-material"}). Specimens obtained from patients with dolichocolon and idiopathic megacolon exhibited spontaneous activity of variable intensity. Spontaneous activity was not observed in 5 out of 10 longitudinal specimens from patients of the control group and in only 2 out of 16 specimens from patients with CC. Spontaneous activity was detected in all samples of circular fibers. Some specimens showed regular and irregular phasic contractions of different frequencies and amplitudes, while others demonstrated long phasic contractions without relaxation. Similar types of spontaneous activity were observed in smooth muscle strips of both groups. Examples of spontaneous activity of resected human colon specimens are shown in [Fig 1](#pone.0235985.g001){ref-type="fig"}.

![Spontaneous contractile activity of circular smooth muscle prepared from specimens of human descending colon from patients of the control group (**A, B, C, D, E**) and the slow transit (CC) group (**F, G, H, I, J**). The dashed line is set at the level of maximum relaxation.](pone.0235985.g001){#pone.0235985.g001}

We used KCl (70 mM) or carbachol (0.01--200 μM) to assess the evoked contractility of circular and longitudinal smooth muscles ([Fig 2](#pone.0235985.g002){ref-type="fig"}). The average amplitudes of the contractions are shown in [Table 1](#pone.0235985.t001){ref-type="table"}. Both the circular and longitudinal muscles of CC patients exhibited increased amplitude of contractions compared to the control group ([Table 1](#pone.0235985.t001){ref-type="table"}). Carbachol induced a dose-dependent increase in the contractions of circular and longitudinal muscle specimens. However, the contractile responses of longitudinal strips were more variable ([Fig 2A and 2B](#pone.0235985.g002){ref-type="fig"}). In specimens from CC patients, contractions of higher amplitude were observed starting at 1 μM of carbachol. For the circular specimens, EC~50~ was 0.760 ± 0.063 μM in the CC group and 2.005 ± 1.046 μM in the control group ([Fig 2A](#pone.0235985.g002){ref-type="fig"}). For the longitudinal specimens, EC~50~ was 0.649 ± 0.141 μM in the CC group and 0.504 ± 0.047 μM ([Fig 2B](#pone.0235985.g002){ref-type="fig"}) in the control group.

![Carbachol-evoked contractions of descending colon strips from patients with CC (**A, B**). Dose-response effects of carbachol on the amplitude of contraction of circular (A**a**) and longitudinal (**Ba**) muscle strips in the control (white squares) and the CC groups (white circles). The amplitudes were normalized by the weight of specimens in each experiment. \* p \< 0.05; \*\* p \< 0.01. Examples of contractions of circular (**Ab**) and longitudinal (**Bb**) muscle strips in the control and the CC groups in response to the application of carbachol (10 μM).](pone.0235985.g002){#pone.0235985.g002}

10.1371/journal.pone.0235985.t001

###### Amplitudes of KCl- and carbachol-evoked contractions of longitudinal and circular muscle specimens in the control (n = 5) and CC (n = 8) groups (mean ± SEM).

![](pone.0235985.t001){#pone.0235985.t001g}

                    Longitudinal   Circular                                
  ----------------- -------------- ------------------------- ------------- ---------------------------
  KCl               0.050±0.006    0.129±0.026 (p = 0.028)   0.073±0.014   0.192±0.033 (p = 0.028)
  Carbachol 10 μM   0.105±0.014    0.283±0.064 (p = 0.014)   0.287±0.037   0.555±0.068 (p = 0.00988)

Intra- and inter-individual variability of intestinal microbiota among constipated subjects {#sec012}
-------------------------------------------------------------------------------------------

The study enrolled fifteen constipated patients with an average age of 42 years (σ = ±14, range: 20--70 years) and gender distribution 3/12 (m/f) ([S1 Table](#pone.0235985.s002){ref-type="supplementary-material"}). Colonic tissue samples were obtained during colectomy for CC to assess the microbiota composition by the conventional culture method and 16S rRNA-based sequencing analysis. The microbiological studies revealed significant inter-individual differences in the colonic mucosal microbiota of constipated patients ([Table 2](#pone.0235985.t002){ref-type="table"}). MiSeq-mediated sequencing of the samples produced a total of 1,478,190 reads with an average of 98,546 ± 31,776 reads per sample ([S2 Table](#pone.0235985.s003){ref-type="supplementary-material"}). Raw sequence reads were deposited in NCBI Sequence Read Archive (SRA) under BioProject ID PRJNA590365 (<https://www.ncbi.nlm.nih.gov/sra/PRJNA590365>). Reads were further processed and analyzed using QIIME software, version 1.9.1 \[[@pone.0235985.ref036]\]. Joined paired-end reads were processed to remove low quality and chimeric sequence data. After quality filtering, chimera filtering, and rarefying, we analyzed 402,647 filtered reads, with an average of 26,843 ± 259 filtered reads per sample ([S2 Table](#pone.0235985.s003){ref-type="supplementary-material"}). Sequences were clustered into operational taxonomic units (OTU) based on the 97% identity threshold (open reference-based OTU picking strategy), the latest GreenGenes database version 13.8 \[[@pone.0235985.ref037]\] was used. Averages of 460 OTUs were identified across our dataset, with a minimum of 201 OTUs and a maximum of 592 OTUs. Alpha diversity indices were calculated using Chao1, Shannon, and Simpson metrics to characterize the richness and evenness of the bacterial community ([S3 Table](#pone.0235985.s004){ref-type="supplementary-material"} or [Fig 3](#pone.0235985.g003){ref-type="fig"}).

![Evaluation of the alpha- (**A**) and beta-diversity (**B**). Panel **A** reports rarefaction curves based on the number of observed OTUs at increasing sequencing depth of the samples. Panel **B** shows the predicted PCoA. Datasets from men and women are colored in blue and red, respectively. Eight samples are grouped into a cluster, thus highlighting the similarity of their phylogenetic microbiota composition.](pone.0235985.g003){#pone.0235985.g003}

10.1371/journal.pone.0235985.t002

###### Gut microbiota in patients with chronic constipation assessed by culture method.

![](pone.0235985.t002){#pone.0235985.t002g}

  Samples   Groups of microorganisms, lg CFU/g                                                                        
  --------- ------------------------------------ ------------ ------------- ------------- ------------- ------------- -----------
  **1**     4±0.001                              3±0.001      ND            ND            ND            ND            ND
  **2**     2.85±0.21                            1.24±0.34    5.92±4.35     Sporadic      ND            ND            ND
  **3**     5.31±0.01                            4.43±0.07    4.23±0.04     4.41±0.09     3.86±0.40     4.35±0.80     3.15±0.21
  **4**     ND                                   ND           7±0.001       ND            ND            ND            ND
  **5**     4.73±0.13                            4.80±0.14    4.27±0.12     5.18±0.32     5.43±0.28     4.75±0.19     5.01±0.03
  **7**     5.91±0.004                           6.24±0.03    4.31±0.08     5.45±0.21     6.06±0.12     5.87±0.04     5.73±0.07
  **8**     8.45±0.06                            9.64±0.40    10.20±0.001   10.28±0.001   6.86±0.21     5.82±0.31     ND
  **9**     3±0.001                              ND           ND            ND            ND            ND            ND
  **10**    ND                                   ND           ND            9±0.001       ND            ND            ND
  **11**    Sporadic                             ND           ND            ND            ND            ND            ND
  **12**    15.13±0.07                           14.00±0.03   14.21±0.02    13.03±0.03    14.22±0.02    15.93±0.75    ND
  **13**    4.78±0.06                            3.12±0.12    3.89±0.09     3.27±0.11     3.36±0.23     ND            ND
  **14**    ND                                   ND           ND            ND            3±0.001       ND            ND
  **15**    13.35±0.05                           7.35±0.10    11.71±0.004   11.93±0.28    12.11±0.001   12.32±0.001   ND

Data are shown as mean ± SD. ND--not detected

The rarefaction curves we obtained showed that the retrieved sequencing data were adequate in all cases to cover the vast majority of biodiversity contained within the samples. Surprisingly, species diversity in colon tissue samples was lower than in stool samples, which are frequently used in similar studies of the gut microbiota of constipation.

To evaluate the inter-individual differences between gut microbiota of constipated patients, we assessed the beta-diversity characteristics \[[@pone.0235985.ref036]\], which were estimated using unweighted Unifrac measures \[[@pone.0235985.ref038]\] with further visualization through Principal Coordinate Analysis (PCoA). The PCoA plot showed that eight samples could be grouped into a cluster, thus highlighting the similarity of their phylogenetic microbiota composition. These eight samples belonged to women aged 20--53 years ([Fig 3B](#pone.0235985.g003){ref-type="fig"}). However, overall beta-diversity analyses did not reveal age- and sex-related clustering of the samples. Likewise, the microbiota composition of the samples was not associated with the type of colon pathology (dolichocolon or megacolon). Our results indicate that other genetic and environmental factors influence the phylogenetic diversity of the gut microbiomes during constipation.

Taxonomic profiling of the gut microbiota of patients with CC {#sec013}
-------------------------------------------------------------

We detected a total of 18 prokaryotic phyla in the gut microbiomes of constipated patients, including four frequently detected phyla, *Firmicutes*, *Bacteroidetes*, *Proteobacteria*, and *Actinobacteria*, and 14 minor phyla, *Euryarchaeota*, *Acidobacteria*, *Cyanobacteria*, *Elusimicrobia*, *Fusobacteria*, *Lentisphaerae*, *Planctomycetes*, *Spirochaetes*, *Synergistetes*, TM7, *Tenericutes*, *Verrucomicrobia*, WPS-2, and \[*Thermi*\] ([Fig 4](#pone.0235985.g004){ref-type="fig"}, [S4 Table](#pone.0235985.s005){ref-type="supplementary-material"}). The four frequently detected phyla were present in all samples, whereas each of the phyla *Acidobacteria*, *Elusimicrobia*, *Planctomycetes*, and *Spirochaetes*, was detected in only one sample. When analyzed at the genus level, the most frequently detected taxa in the samples were *Bacteroides* (18.0% ± 14.9%) along with unclassified members of the *Ruminococcaceae* (9.8% ± 7.3%), *Lachnospiraceae* (9.5% ± 6.9%), and *Enterobacteriaceae* families (8.0% ± 10.9%), and the *Prevotella* genus (5.5% ± 6.9%) ([S5 Table](#pone.0235985.s006){ref-type="supplementary-material"}).

![Phylum distribution in gut microbiomes of the constipated patients.\
(**A**) Average phylum distribution of the gut microbiomes of constipated patients; (**B**) phylum distribution of individual microbiomes.](pone.0235985.g004){#pone.0235985.g004}

We also compared the gut microbiota profiles obtained using culture methods ([Table 2](#pone.0235985.t002){ref-type="table"}) with those obtained by 16S rDNA gene sequencing ([S5 Table](#pone.0235985.s006){ref-type="supplementary-material"}). As a result, we found discrepancies in the abundance of certain groups of bacteria, depending on the method used. Thus, five samples were tested negative for the 16S rRNA gene of *Lactobacillus* spp. but produced colonies when were inoculated on MRS agar, which is recommended for the cultivation of *Lactobacillus* spp. This may be attributed to the limited selectivity of the nutrient medium. In contrast, LAB, which were found in all tested samples by metagenomic studies of 16S rRNA, were not detected by culture-based technique in five samples. Similarly, bifidobacteria and enterobacteria, which were present according to the results of 16S rRNA gene sequencing, were not detected by culture method in five and eight samples, respectively. These sequences, revealed by genomic approaches, probably corresponded to uncultivated species and strictly anaerobic microorganisms that could not be detected by culture method.

Discussion {#sec014}
==========

CC is one of the most common gastrointestinal disorders. The majority of CC patients do not present organic pathology and are easily managed with medical treatment, including diet modification, exercise, and laxatives. However, there are severe forms associated with slow transit that are refractory to medical treatment. Idiopathic megacolon and dolichocolon are rare conditions that affect men and women equally and are associated with a permanently enlarged diameter or/and redundant colon \[[@pone.0235985.ref005], [@pone.0235985.ref015]\]. The pathogenesis of idiopathic megacolon is still unclear. Abnormalities of the enteric nervous system and alterations in the function of smooth muscle cells and connective tissue elements have been suggested to be involved in gut dysmotility \[[@pone.0235985.ref005], [@pone.0235985.ref013], [@pone.0235985.ref015]\]. Growing evidence indicates that intestinal microbiota may contribute to constipation and constipation-related symptoms \[[@pone.0235985.ref039]\]. However, the microbiota of patients with idiopathic megacolon and dolichocolon was not investigated. In this study, we analyzed the functional activity of smooth muscle cells and the gut microbiota of colonic tissue samples from constipated patients with megacolon and dolichocolon.

It is known that the contractile activity of the intestine is provided by longitudinal and circular smooth muscles whose contractions are coordinated by the central and enteric nervous systems, interstitial cells of Cajal, hormones, and autocrine and paracrine factors \[[@pone.0235985.ref040]\]. The contraction of smooth muscle cells is initiated by Ca^2+^ ions, activation of Ca-calmodulin dependent protein kinase with subsequent activation of myosin light chain kinase (MLCK) \[[@pone.0235985.ref040], [@pone.0235985.ref041]\]. In our study, the specimens obtained from patients with CC demonstrated spontaneous activity and the ability to contract in response to depolarization, which indicates that molecular mechanisms of the contractile activity were not impaired in the smooth muscle cells. Moreover, the maximum amplitudes of contractions in response to KCl application were larger compared to the control group.

One of the most important mechanisms that control the contractile activity of the human colon is the activation of the parasympathetic system and the release of acetylcholine, which binds to muscarinic receptors of types 2 and 3 (M~2~ and M~3~ ChRs) \[[@pone.0235985.ref042]\]. Although M~2~ ChRs prevails in the smooth muscle cells of the human colon, contractions in response to cholinomimetics are mainly mediated by M~3~ receptors. M~2~ receptors can enhance the contraction caused by the activation of M~3~ receptors \[[@pone.0235985.ref043]\], and their role increases in pathologies \[[@pone.0235985.ref044]\]. Previous studies with stimulation of colon strips from patients with CC demonstrated controversial results. Other researchers have observed a decrease \[[@pone.0235985.ref045]\] in contractile responses or a lack of difference in the amplitudes of carbachol-evoked contractions \[[@pone.0235985.ref046]\] in CC patients. We showed that EC~50~ for carbachol-evoked contractions was lower in the CC group, and the dose-response curves were shifted to the left, thus indicating an increased sensitivity to stimulating factors. Similarly to our results, it has been shown that smooth muscle cells in circular specimens of the sigmoid colon from patients with CC and diverticulosis exhibit an increased sensitivity to carbachol \[[@pone.0235985.ref020]\]. Hypersensitivity to cholinergic stimulation can be explained by the development of a secondary denervation syndrome, which is consistent with anomalies of intramural plexuses \[[@pone.0235985.ref047]\] observed in patients with CC and confirmed by functional cholinergic deficiency in response to electrical stimulation of intramural nerves \[[@pone.0235985.ref018]\]. Besides a reduced quantity of neurons, the number of neurons containing choline acetyltransferase decreased \[[@pone.0235985.ref048]\]. Increased expression of M~3~ ChRs in smooth muscle cells has also been observed in patients with diverticulosis \[[@pone.0235985.ref029]\], which might be a compensatory mechanism for reduced cholinergic innervation. At the same time, cholinesterase reduced colonic motor activity in patients with CC, whereas the inhibitor of choline esterase (edrofonium chloride) did not change the activity of the descending colon in patients with constipation \[[@pone.0235985.ref021]\]. These results could be explained by changes in the local environment of smooth muscle cells, atrophy of the mucous and muscular layers, inflammation, which impair the nervous regulation, sensitivity of contractile proteins, ion channels, and receptors \[[@pone.0235985.ref049], [@pone.0235985.ref050]\]. Also, the effects of exogenous or endogenous modulators able to inhibit the contractile activity of smooth muscle cells cannot be excluded. In particular, the intestinal microbiota may contribute to the pathogenesis of functional gastrointestinal disorders \[[@pone.0235985.ref039]\].

We used the culture method and 16S rRNA metagenomic analysis to study the gut microbiota in colonic tissue samples obtained from patients who had undergone colectomy for refractory forms of chronic constipation. Colonic tissue samples are seen as a direct approach, in contrast to fecal or mucosal samples, since they thoroughly replicate the profiles of the intestinal microbiota and provide thorough knowledge on the gut microbiome of patients with constipation.

Similar to previous descriptions \[[@pone.0235985.ref023], [@pone.0235985.ref026]\], we identified a preponderant presence of the genus *Bacteroides* in the gut of constipated patients (18.0% ± 14.9%). Being commensal, members of the genus *Bacteroides* account for about 25% of the total bacterial population in the adult human gut \[[@pone.0235985.ref051]\] and play a key role in the development and maintenance of intestinal sensory and motor functions \[[@pone.0235985.ref022]\]. For instance, *Bacteroides thetaiotaomicron* has been demonstrated to stimulate gut motility by increasing the expression of γ-aminobutyric, vesicle-associated protein-33, and enteric γ-actin \[[@pone.0235985.ref052]\]. In fact, according to 16S rDNA metagenomic profiling of fecal samples from healthy women, *Bacteroides* spp. were more abundant in loose stool of individuals with fast colon transit \[[@pone.0235985.ref053]\]. Concerning the role of *Bacteroides* in constipation, conflicting data have been found in the literature. There are reports on the depletion of the *Bacteroides* genus under functional constipation \[[@pone.0235985.ref026], [@pone.0235985.ref054], [@pone.0235985.ref055]\]. *Bacteroides fragilis* and *Bacteroides ovatus*, on the contrary, were selected as the most discriminative species in children with functional constipation, as opposed to healthy controls \[[@pone.0235985.ref056]\]. On the other side, Zhu *et al*. reported no differences in the *Bacteroides* genus content between constipated and healthy children \[[@pone.0235985.ref023]\]. In our study, 15.23% of reads belonging to the *Bacteroides* genus corresponded to unknown species, followed by *Bacteroides fragilis* (1.94%), and other species (*B*. *uniformis* (0.57%), *B*. *ovatus* (0.14%), *B*. *plebeius* (0.08%), *B*. *eggerthii* (0.02%), *B*. *caccae* (0.0036%), thus indicating that further genomic analyses are still needed to shed light on the biological role of this genus in constipation.

In previous studies, particular attention was given to butyrate-producing genera, such as *Coprococcus*, *Roseburia*, and *Faecalibacterium* \[[@pone.0235985.ref057]\]. Zhu *et al*. \[[@pone.0235985.ref023]\] reported that these taxa were more abundant in constipated obese children than in healthy controls. Conversely, Mancabelli *et al*. \[[@pone.0235985.ref026]\] demonstrated the depletion of *Roseburia* and *Coprococcus 3* in functionally constipated individuals, while *Faecalibacterium* content significantly increased. Butyrate was shown to produce opposite effects on gut motility: stimulation at low and inhibition at higher concentrations \[[@pone.0235985.ref058], [@pone.0235985.ref059]\]. Interestingly, fecal butyrate producers (i.e., *Faecalibacterium*, *Roseburia*, and *Coprococcus*) were associated with fast colonic transit \[[@pone.0235985.ref060]\], presumably because of induction of serotonin release and facilitating of cholinergic pathways by butyrate \[[@pone.0235985.ref061], [@pone.0235985.ref062]\]. On the other hand, mucosal butyrate producers (i.e. *Faecalibacterium*) were associated with constipation \[[@pone.0235985.ref060]\]. Several colonic effects of butyrate, such as inhibition of mucin secretion \[[@pone.0235985.ref063]\], reduction of stool volume \[[@pone.0235985.ref064]\] via stimulation of colonic water and electrolyte absorption \[[@pone.0235985.ref065]\], and inhibition of colonic smooth muscle contraction \[[@pone.0235985.ref059]\], could predispose to constipation. The butyrate-producing genera (*Roseburia*, 0.5% ± 0.008%; *Coprococcus*, 1.5% ± 0.019%; *Faecalibacterium*, 1.0% ± 0.014%) were present in our dataset as well, but in lower amounts compared to the data from previous metagenomic studies \[[@pone.0235985.ref023], [@pone.0235985.ref026]\]. Thus, chronic constipation in analyzed patients was not likely to be determined by the motility-inhibiting effect of butyrate-producing genera in the gut.

Previous metagenomic studies have identified 23 microbial taxa uniquely present in healthy individuals and absent in constipated subjects \[[@pone.0235985.ref026]\]. However, four of these genera, namely *Methanobrevibacter*, *Sedimentibacter*, *Leptotrichia*, and *Acinetobacter*, were found in our study. Thus, our results corroborate current opinion about the lack of specific microbial biomarkers whose presence or absence is associated with constipation and point at a probable role played by the overall gut microbiota at the functional level.

According to our data, *Akkermansia muciniphila* was in the top 10 most abundant species in the gut microbiota of the patients with chronic constipation (2.71%). Remarkably, the amount of *A*. *muciniphila* was highly variable: the taxon was not found in eight tested samples, while in seven samples, it varied from \<1 (0.015)% up to 19.34%. *A*. *muciniphila* is an anaerobic Gram-negative mucin-degrading bacterium of the phylum *Verrucomicrobia* \[[@pone.0235985.ref066]\]. It usually inhabits the large intestine and accounts for approximately 3% of intestinal bacteria \[[@pone.0235985.ref067], [@pone.0235985.ref068]\]. The presence of *A*. *muciniphila* is associated with a healthy intestine, and its abundance is correlated to several disease states \[[@pone.0235985.ref066], [@pone.0235985.ref068]--[@pone.0235985.ref073]\], such as irritable bowel syndrome (IBS) \[[@pone.0235985.ref068], [@pone.0235985.ref071]\], acute appendicitis \[[@pone.0235985.ref072]\], obesity \[[@pone.0235985.ref070]\], and colorectal cancer \[[@pone.0235985.ref069], [@pone.0235985.ref073]\]. Although its role in human microbiome is still poorly understood, *A*. *muciniphila* is considered a beneficial microbe because of its effects on glucose and lipid metabolism and intestinal immunity \[[@pone.0235985.ref074]\]. To date, only a few studies have investigated the relationship between *Akkermansia* and chronic constipation. *Akkermansia* content increased in pseudo-germ-free mice after transplantation of fecal microbiota from patients with constipation. It was suggested that *Akkermansia* induced a depletion of the fecal water content due to degradation of intestinal mucin and, finally, impaired the intestinal mucosal barrier \[[@pone.0235985.ref075]\]. In this context, Vandeputte *et al*. \[[@pone.0235985.ref053]\] reported that *Akkermansia* populations increased with stool firmness and, thus, were more prevalent in slow transit individuals.

It is noteworthy that the abundance of common probiotic genera (*Bifidobacterium* and *Lactobacillus*) in the constipated patients did not decrease. *Bifidobacterium* spp. were detected in all analyzed samples, ranging from \<0.1% up to 10.69%. Except for a small part of unclassified reads (0.22%), OTUs belonging to the *Bifidobacterium* genus were classified as *Bifidobacterium longum* (0.96%), *B*. *adolescentis* (0.36%), and *B*. *pseudolongum* (0.07%). Thus, the relative abundance and species representativity of bifidobacteria corresponded to those of healthy adults \[[@pone.0235985.ref076]\]. *Lactobacillus* spp. were observed in 11 out of 15 analyzed samples (73.3%) with a relative abundance of 0.1% ± 0.001%. So, their content did not differ significantly from that in healthy gut microbiota, where they normally constitute only a minor fraction, around 0.01 to 0.6% of total bacterial counts \[[@pone.0235985.ref077], [@pone.0235985.ref078]\]. Similarly, Zhu *et al*., using 16S rRNA gene pyrosequencing, demonstrated that the levels of *Lactobacillus* and *Bifidobacteria* species were not reduced in children with functional constipation \[[@pone.0235985.ref023]\]. Conversely, Khalif *et al*. \[[@pone.0235985.ref055]\] showed that the levels of *Bifidobacteria* and *Lactobacillus* significantly decreased in adult patients with constipation, perhaps, indicating a decrease in physiologically active representatives of these genera, because their conclusion was based on culture methods. Our results cast doubt on the efficacy of conventional probiotic treatment to restore the ecology of the gut microbiota in constipated patients.

Conclusions {#sec015}
===========

Thus, in this study we have demonstrated that the spontaneous motor activity of smooth muscle cells remains unchanged in patients with CC. Moreover, we detected an increased sensitivity to KCl- and carbachol-evoked contractions in circular and longitudinal muscle strips of the descending colon. Based on the previous data, we can suggest that smooth muscle cells develop a compensatory response to the abnormality in cholinergic stimulation.

Herein, we analyzed for the first time the gut microbiota composition of colon samples which thoroughly reflect the gut microbiota profiles of patients with refractory forms of CC. The results of this study suggest that the gut microbiome of constipated patients comprises typical gut bacteria along with significant inter-individual differences. Our data showed that these discrepancies were not affected by age, sex, and colonic anatomy (dolichocolon, megacolon). No definitive association was observed between constipation and the abundance or lack of certain prokaryotic taxa in the gut microbiome. Special attention was given to microbes that may affect motility via the production of metabolites. The butyrate-producing genera (*Roseburia*, *Coprococcus*, *Faecalibacterium*) were identified in low amount and, therefore, were not likely to promote motility-inhibiting activity. Our results showed that the abundances of common probiotic genera *Bifidobacterium* and *Lactobacillus* were not reduced, thus compromising the efficacy of conventional probiotic treatment to restore the ecology of the gut microbiota in constipated patients. Nevertheless, due to the limited number of samples, additional experiments are needed to validate these observations.
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###### Examples of abdominal computer tomography (CT) images in coronal section to illustrate the large colonic diameters.

**A---**patient K., 23-year-old. Elongated transverse colon, sags in the small pelvis. Diagnosis: total dolichocolon, ptosis of the transverse colon; chronic constipation, stage of decompensation. **B**---patient M., 64-year-old. Total extension of the colon filled with fecal masses. Diagnosis: idiopathic megacolon; chronic constipation, stage of decompensation.
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